Table 1.
Characteristics | Statistic |
---|---|
Age (years), mean (range) | 34 (21–46) |
Years diagnosed with RA, median (IQR) | 10 (2–16) |
Language, n (%) | |
English | 20 (95) |
French | 1 (5) |
Canadian province of residence, n (%) | |
British Columbia | 9 (43) |
Ontario | 7 (33) |
Nova Scotia | 2 (10) |
Other (i.e. Alberta, New Brunswick, Québec) | 3 (14) |
Geographic residencea | |
Rural | 5 (24) |
Urban | 16 (76) |
Ancestry, n (%)b | |
White | 15 (71) |
Asian | 5 (24) |
Black | 1 (5) |
Hispanic | 1 (5) |
Indigenous | 1 (5) |
Highest level of education, n(%) | |
Post-secondary (university, college, technical school, etc.) | 21 (100) |
Current employment status, n (%)b | |
Employed full time (40 or more hours per week) | 14 (67) |
Student | 4 (19) |
Employed part time (less than 40 hours per week) | 2 (10) |
Unable to work | 2 (10) |
Unemployed and looking for work | 1 (5) |
Household income (CAD dollars), n (%)c | |
150,000 and over | 5 (25) |
120,000 to 150,000 | 2 (10) |
90,000 to 120,000 | 6 (30) |
60,000 to 90,000 | 2 (10) |
30,000 to 60,000 | 5 (25) |
Current members of household, median (IQR) | 3 (2 – 4) |
Marital status, n (%) | |
Married | 13 (62) |
Common-law or co-habiting | 5 (24) |
Single, never married | 3 (14) |
Plan to have future children, n (%) | 12 (57) |
Future family planning options considered, n (%)b | |
Childbearing | 12 (100) |
Adoption | 5 (42) |
Other (i.e. surrogacy or assisted fertilisation) | 4 (33) |
Medications taken for RA, n (%)b, d | |
Traditional DMARDs | |
Antimalarials (i.e. hydroxychloroquine, chloroquine) | 19 (91) |
Methotrexate | 15 (71) |
Sulfasalazine | 14 (67) |
Leflunomide | 4 (19) |
Azathioprine | 2 (10) |
Gold salts | 1 (5) |
Cyclosporine | 1 (5) |
Targeted DMARDs | |
Anti-tumour necrosis factor (anti-TNF) agents | 13 (62) |
Others (e.g. abatacept, rituximab, tocilizumab, tofacitinib) | 7 (33) |
aRural is defined as less than 400 people per square kilometre. Urban is define as more than 400 people per square kilometre
bCumulative percentage may be greater than 100, as multiple categories may be relevant to each participant
cMissing response from one participant
dDefined as any medication the participant has been exposed over the course of their RA treatment